1. Home
  2. XAIR vs IRIX Comparison

XAIR vs IRIX Comparison

Compare XAIR & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$2.66

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.62

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
IRIX
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
15.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XAIR
IRIX
Price
$2.66
$0.62
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 120.7K
44.3K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 51.85
EPS
N/A
★ N/A
Revenue
$7,679,000.00
★ $41,593,000.00
Revenue This Year
$122.00
$3.07
Revenue Next Year
$58.15
$6.66
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 107.26
N/A
52 Week Low
$0.33
$0.61
52 Week High
$8.19
$1.65

Technical Indicators

Market Signals
Indicator
XAIR
IRIX
Relative Strength Index (RSI) 33.24 35.05
Support Level $0.41 $0.61
Resistance Level $2.66 $0.98
Average True Range (ATR) 0.20 0.03
MACD -0.01 0.01
Stochastic Oscillator 29.43 27.74

Price Performance

Historical Comparison
XAIR
IRIX

About XAIR Beyond Air Inc.

Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: